Since there is still no cure for dengue, Millan added that the vaccine will not completely eliminate the risk of dengue in recipients. Instead, it will help prevent severe dengue cases. “This will just prevent us from having severe dengue. It also decreases the chance of hospitalization due to dengue,” she stressed, citing that the vaccine could reduce the risk of severe dengue by up to 60 percent. Meanwhile, the first-generation vaccine, CYD-TDV, which is available in 20 countries, is limited to persons with previous dengue infections.